Search

everythinglearnresearchcommunity

for

Search:↓

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

Dermatologists helped identify COVID-19 through skin symptoms and managed skin issues during the pandemic, but more high-quality research is needed.

The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.

Patients with metabolic syndrome often have skin problems like acanthosis nigricans and skin tags, and early treatment is important to prevent serious issues.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Fullerene C60 shows promise as a new treatment for various skin conditions.

Cosmeceuticals are important for managing skin issues during the COVID-19 pandemic.

People with chronic Hepatitis C often have skin problems like itching and contact dermatitis, especially older individuals and women.

Some skin symptoms, like chilblain-like lesions, can help identify COVID-19 and show how the immune system is responding.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

Cri-du-chat syndrome can cause skin and oral lesions affecting nutrition and quality of life.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Asylum seekers arriving by boat may face skin problems due to harsh conditions, and doctors should use a thorough skin assessment approach to diagnose and treat them effectively.

People with Down's syndrome often have more skin problems due to a weak immune system.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Trichostasis spinulosa can be diagnosed with a simple skin biopsy and treated with specific gels, but lesions may return after stopping treatment.

The document suggests a possible connection between rapid weight loss and hair loss, and reports a case of skin condition improvement after stopping acne medication.

Patients on long-term hemodialysis often have skin problems related to their treatment.

Psychotropic drugs can cause hair loss or excessive hair growth.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

The document reviews key historical figures and discoveries in dermatology.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.